For the composite value including all ADARs (ADAR1 + ADAR2-ADAR3) as used in prior studies4, AD patients have the lowest value, while MCI subjects are in the middle and controls have the highest value (P = 0.03). This evidence concerns the gene ADARB2 and Alzheimer disease.